Haemonetics (HAE) Tops Q2 EPS by 2c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.52 -0.19%
Revenue Growth %: +5.5%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +5.5%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.56, $0.02 better than the analyst estimate of $0.54. Revenue for the quarter came in at $242 million versus the consensus estimate of $233.45 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
